Tasigna (nilotinib) Capsules
NOVARTIS ONCOLOGY
IMPORTANT SAFETY INFORMATION

What is the most important information to know about TASIGNA?

TASIGNA can cause a possible life-threatening heart problem called QT prolongation.

QT prolongation causes an irregular heartbeat, which may lead to sudden death.

Your doctor should check your heart with a test called an "ECG":

  • Before taking TASIGNA
  • 7 days after starting TASIGNA
  • Regularly during treatment
  • After any dose changes
TASIGNA Education

TASIGNA Education

Learn more about TASIGNA (nilotinib) 200-mg capsules for the treatment of a type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adult patients who: are no longer benefitting from another treatment, including treatment with imatinib (Gleevec®); have taken other treatments and cannot tolerate them. (Click here for important Gleevec safety information and full Prescribing Information.) The effectiveness of TASIGNA is based on hematologic and cytogenetic response rates. There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Find out how TASIGNA works and what you need to know to take TASIGNA correctly.

About TASIGNA

Learn more about TASIGNA for Ph+ CML in adult patients in chronic or accelerated phase who are resistant to or intolerant of prior treatment, including Gleevec.

How to Take TASIGNA

Be sure you take TASIGNA exactly as prescribed.

Monitoring Ph+ CML

Understand the laboratory tests that help your doctor monitor whether or not you are responding to your TASIGNA treatment.

Prescribing Information

Download the complete Prescribing Information for TASIGNA in PDF format.

print this page  print this page E-mail this page
Ph+ CML Education and Information

Ph+ CML Education

What is Ph+ CML? What does resistance mean? Learn more about Ph+ CML here.


Important Information about TASIGNA

TASIGNA (nilotinib) 200-mg capsules is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy that included imatinib. The effectiveness of TASIGNA is based on hematologic and cytogenetic response rates. There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival.

What is the most important information to know about TASIGNA?

TASIGNA can cause a possible life-threatening heart problem called QT prolongation.

QT prolongation causes an irregular heartbeat, which may lead to sudden death.

Your doctor should check your heart with a test called an "ECG":

  • Before taking TASIGNA
  • 7 days after starting TASIGNA
  • Regularly during treatment
  • After any dose changes

You may lower your chances for having QT prolongation with TASIGNA if you:

Food can affect the levels of TASIGNA in your body, which can lead to serious side effects. Taking TASIGNA on an empty stomach may lower your chances of having a possibly life-threatening heart problem called QT prolongation.

QT prolongation causes an irregular heartbeat, which may lead to sudden death.

Take TASIGNA:

TASIGNA is a prescription medication.

TASIGNA comes in 200 mg capsules. Your doctor will prescribe 400 mg of TASIGNA to be taken twice a day for a total daily dose of 800 mg. Each dose should be taken approximately 12 hours apart.

Swallow TASIGNA capsules whole with water.

Before taking TASIGNA

Talk to your doctor or pharmacist about all other medication(s) you may be taking, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements, since they may affect how TASIGNA works and increase your chance of serious and life-threatening side effects.

Tell your doctor if:

Call your doctor right away if you faint or have an irregular heartbeat while taking TASIGNA.

These can be symptoms of QT prolongation.

Call your doctor immediately if you experience any of these symptoms.

Serious side effects

TASIGNA is sometimes associated with serious side effects, with symptoms that include:

Common side effects

Most patients experience side effects at some time. Some common side effects you may experience include:

Be sure to tell your doctor or pharmacist if you have any side effects during treatment with TASIGNA.

Tell your doctor if you are pregnant or planning to become pregnant. TASIGNA can harm a fetus (unborn baby).

Tell your doctor if you are breast-feeding.

Women should not breast-feed while taking TASIGNA.

If you take too much TASIGNA, call your doctor or poison control center right away.

Your doctor will check your heart, do regular blood tests and take bone marrow samples during treatment with TASIGNA. These are done to check for side effects with TASIGNA and to see how well TASIGNA may be working for you. Your doctor should check your blood to monitor the amount of blood cells (white blood cells, red blood cells, and platelets) during treatment. These should be checked every two weeks for the first two months and then monthly thereafter, or as considered necessary by your doctor.

Your doctor may have you stop TASIGNA for some time or reduce your dose if you have side effects with it. Please see accompanying patient information, including Boxed WARNING, and the TASIGNA Medication Guide you received with your prescription.